Trial Profile
Real world experience with Simeprevir and sofosbuvir for Hepatitis C treatment
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 18 Nov 2015
Price :
$35
*
At a glance
- Drugs Simeprevir (Primary) ; Sofosbuvir (Primary) ; Peginterferon; Ribavirin
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 18 Nov 2015 Planned number of patients changed from 500 to NULL.
- 25 May 2015 New trial record